Rba Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Rba Wealth Management, LLC

$259 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$73.27 - $83.09 $27,476 - $31,158	-375 Reduced 7.21%	4,823 $390,000
Q3 2023 Oct 19, 2023	SELL	$73.94 - $80.67 $30,315 - $33,074	-410 Reduced 7.31%	5,198 $389,000
Q2 2023 Jul 21, 2023	SELL	$76.01 - $86.7 $13,605 - $15,519	-179 Reduced 3.09%	5,608 $432,000
Q1 2023 Apr 17, 2023	SELL	$77.31 - $88.08 $27,058 - $30,828	-350 Reduced 5.7%	5,787 $480,000
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $11,092 - $15,925	-178 Reduced 2.82%	6,137 $0
Q3 2022 Oct 12, 2022	SELL	$59.54 - $68.01 $101,158 - $115,548	-1,699 Reduced 21.2%	6,315 $390,000
Q2 2022 Jul 11, 2022	SELL	$57.72 - $65.01 $45,887 - $51,682	-795 Reduced 9.02%	8,014 $495,000
Q1 2022 Apr 14, 2022	SELL	$57.92 - $72.58 $29,655 - $37,160	-512 Reduced 5.49%	8,809 $524,000
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $604,746 - $686,398	9,321 New	9,321 $677,000
Q2 2021 Jul 22, 2021	SELL	$63.47 - $69.35 $645,109 - $704,873	-10,164 Closed	0 $0
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $27,000 - $30,806	-450 Reduced 4.24%	10,164 $656,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $148,706 - $169,443	-2,625 Reduced 19.83%	10,614 $618,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $149,847 - $188,407	-2,413 Reduced 15.42%	13,239 $837,000
Q2 2020 Sep 29, 2020	SELL	$72.34 - $84.0 $77,403 - $89,880	-1,070 Reduced 6.4%	15,652 $1.2 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $83,110 - $106,451	-1,327 Reduced 7.35%	16,722 $1.25 Million
Q4 2019 Jan 09, 2020	SELL	$61.62 - $67.78 $67,658 - $74,422	-1,098 Reduced 5.73%	18,049 $1.17 Million
Q3 2019 Oct 24, 2019	SELL	$62.51 - $69.0 $73,824 - $81,489	-1,181 Reduced 5.81%	19,147 $1.21 Million
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $70,036 - $78,538	-1,132 Reduced 5.27%	20,328 $1.37 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.34 Million - $1.5 Million	21,460 New	21,460 $1.45 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rba Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rba Wealth Management, LLC with notifications on news.

Account